Hermes Pharma closes FDA inspection
Hermes Pharma, a division of Hermes Arzneimittel GmbH, has announced that the company successfully completed the examination of Germany by the U.S. Food & Drug Administration (FDA) for its manufacturing facility in Wolfratshausen. Hermes Pharma is a manufacturer of dietary supplements in the United States, is to control the first routine inspection of a company Hermes Pharma FDA.
The Wolfratshausen installation, coupled with a production site in Wolfsberg, Austria, Hermes Pharma allows for global customers try to act friendly license forms for distribution and sale in the United States. Both stations are equipped with similar production lines. Friendly forms such as instant drinks, granules, orally disintegrating tablets, effervescent tablets and chewable tablets an opportunity for rapid growth in the market for nutritional supplements, especially for patients who find it difficult to swallow pills. Forms are also becoming increasingly important traction in the pharmaceutical sector, companies that better meet the needs of patients, while diversifying the range of products, strengthening their brands and product life cycle, Hermes Pharma reported in a press release.
The audit includes an examination of the general systems theory, including training, calibration and qualification of equipment, standard operating procedures, protocols and methods. Are more than 800 million effervescent tablets and chewable tablets produced each year in the production plant Hermes Pharma Wolfratshausen. Opened in 1994, the factory for the manufacture of effervescent tablets are sensitive to moisture and optimizes chewable tablets. Weighing, granulation, mixing, packaging and tablets instead of in closed automated distribution systems over 12,400 square meters.